10-QPeriod: Q2 FY2012

UNITEDHEALTH GROUP INC Quarterly Report for Q2 Ended Jun 30, 2012

Filed August 7, 2012For Securities:UNH

Summary

UnitedHealth Group Inc. (UNH) reported strong financial results for the second quarter and first half of 2012, demonstrating consistent growth across its key business segments. Total revenues increased by 8% year-over-year for both the quarter and the first six months, reaching $27.3 billion and $54.5 billion, respectively. Net earnings also saw a healthy increase of 6% for the quarter and 4% for the first half, amounting to $1.3 billion and $2.7 billion. The company's UnitedHealthcare segment continues to be a primary growth driver, with revenues up 8% for the quarter and 7% year-to-date, supported by a significant increase in medical enrollment across commercial, Medicare Advantage, and Medicaid plans. While operational costs, particularly medical costs, rose in line with revenue growth and utilization trends, the company effectively managed its medical care ratio, which remained stable. The Optum segment also contributed to overall revenue growth, albeit with a slight decrease in earnings from operations due to strategic investments and changes in the Medicare Part D business. UNH's balance sheet remains robust, with substantial cash and investment balances, and the company actively returned capital to shareholders through increased dividends and share repurchases, underscoring its financial strength and commitment to shareholder value.

Financial Highlights

53 data points
Beta

Revenue

$27.27B

97.7% Gross Margin

Net Income

$1.34B

4.9% Net Margin

EPS (Diluted)

$1.27

Total Assets

$73.47B

Cash & Equivalents

$11.58B

Free Cash Flow

$1.99B

Financial Statements
Beta
Revenue$27.27B
Cost of Revenue$620.00M
Gross Profit$26.64B
SG&A Expenses$4.08B
Operating Expenses$25.04B
Operating Income$2.23B
Interest Expense$153.00M
Net Income$1.34B
EPS (Basic)$1.30
EPS (Diluted)$1.27
Shares Outstanding (Basic)1.03B
Shares Outstanding (Diluted)1.05B

Key Highlights

  • 1Total revenues grew 8% year-over-year for both the three and six months ended June 30, 2012.
  • 2Net earnings increased by 6% for the quarter and 4% for the first half, indicating solid profitability.
  • 3UnitedHealthcare segment revenue grew 8% for the quarter and 7% year-to-date, driven by increased medical enrollment.
  • 4Medical care ratio remained stable at 81.3% for the quarter, demonstrating effective cost management.
  • 5The company actively returned capital to shareholders, repurchasing $1.8 billion in shares and increasing its quarterly dividend.
  • 6Significant investments were made in acquisitions, totaling $2.4 billion in the first half of 2012, indicating a strategy for growth.
  • 7The company maintained a strong liquidity position with $30.7 billion in cash and investments as of June 30, 2012.

Frequently Asked Questions

The primary driver of revenue growth was the increase in the number of individuals served and premium rate increases within the UnitedHealthcare businesses, as well as overall growth in the OptumHealth business.

Medical costs increased due to membership growth, unit cost inflation, and moderate increases in health system use. However, these increases were partially offset by an increase in net favorable medical cost development. The company also worked to manage these trends through care management programs and network relationships.

UnitedHealth Group actively returns capital through share repurchases and dividends. In the first six months of 2012, the company repurchased $1.8 billion of its common stock and increased its quarterly cash dividend rate. As of June 30, 2012, there was authorization to repurchase up to an additional 109 million shares.

The company faces various risks and uncertainties, including regulatory changes related to the Patient Protection and Affordable Care Act, potential government program rate reductions (Medicare and Medicaid), litigation, government investigations, and competitive pressures in the health insurance market. The company also notes the potential impact of changes in medical cost trends and operational efficiencies.